Syensqo SA/NV
SYENS | BR
Overview
Corporate Details
- ISIN(s):
- BE0974464977 (+3 more)
- LEI:
- 549300060XNJ90PLNS10
- Country:
- Belgium
- Address:
- RUE DE LA FUSÉE 98, 1130 BRUSSELS
- Website:
- https://www.syensqo.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
At Syensqo, we’re explorers: experts in science and passionate about all its possibilities. Our innovative products and solutions help enhance the way people around the world live life every day: how they work, travel, and spend leisure time. Inspired by the legacy of the Solvay Congresses, which brought together the greatest scientific minds to explore answers to the world’s biggest challenges, we strive to break new ground: addressing the critical needs of today and creating solutions for the future. We’re constantly expanding on what’s seemingly impossible and pushing the limits of what can be realized. With a diverse global team of more than 13,000 employees in 30 countries, we work together to advance science and help humanity move forward.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-31 07:10 |
Transaction in Own Shares
20250731_Share_Buyback_Start4_EN.pdf
|
English | 240.3 KB | |
| 2025-07-31 07:10 |
Transaction in Own Shares
20250731_Share_Buyback_Start4_FR.pdf
|
French | 242.3 KB | |
| 2025-07-31 07:10 |
Transaction in Own Shares
20250731_Share_Buyback_Start4_NL.pdf
|
Dutch | 243.0 KB | |
| 2025-07-31 07:00 |
Interim Report
2025Q2_FinancialReport_EN_vFINAL (2).pdf
|
English | 2.4 MB | |
| 2025-07-31 07:00 |
Earnings Release
2025Q2_FinancialReport_FR_vFINAL (1).pdf
|
French | 2.5 MB | |
| 2025-07-31 07:00 |
Investor Presentation
2025Q2_FinancialReport_NL_vFINAL (1).pdf
|
Dutch | 2.5 MB | |
| 2025-07-31 07:00 |
Earnings Release
2025Q2_PR_EN_FINAL (2).pdf
|
English | 1.2 MB | |
| 2025-07-31 07:00 |
Earnings Release
2025Q2_PR_FR_FINAL (1).pdf
|
French | 1.3 MB | |
| 2025-07-31 07:00 |
Earnings Release
2025Q2_PR_NL_FINAL (1).pdf
|
Dutch | 1.3 MB | |
| 2025-07-30 17:45 |
Transaction in Own Shares
20250730_3rd_tranche_completion_EN.pdf
|
English | 216.4 KB | |
| 2025-07-30 17:45 |
Transaction in Own Shares
20250730_3rd_tranche_completion_FR.pdf
|
French | 223.7 KB | |
| 2025-07-30 17:45 |
Transaction in Own Shares
20250730_3rd_tranche_completion_NL.pdf
|
Dutch | 275.4 KB | |
| 2025-07-11 08:30 |
Major Shareholding Notification
Syensqo SA_2025-07-07_Issuer_signed.pdf
|
English | 242.8 KB | |
| 2025-07-11 08:30 |
Declaration of Voting Results & Voting Rights Announcements
20250711_BlackRock_Notification_EN.pdf
|
English | 425.4 KB | |
| 2025-07-11 08:30 |
Major Shareholding Notification
20250711_BlackRock_Notification_FR.pdf
|
English | 429.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-11-12 | Thorne Rosemary | Executive member | Buy | 200 | 15,491.02 EUR |
| 2024-08-02 | Roger Davis Christopher | Executive member | Buy | 1,365 | 99,263.75 EUR |
| 2024-06-12 | de Viron Françoise | Board | Buy | 1,020 | 94,166.40 EUR |
| 2024-05-24 | van de Kerkhof Heike | Board | Buy | 380 | 35,597.80 EUR |
| 2024-05-24 | Thorne Rosemary | Board | Buy | 200 | 18,780.18 EUR |
| 2024-04-10 | Kadri Ilham | Executive member | Buy | 26,525 | N/A |
| 2024-04-09 | Roger Davis Christopher | Executive member | Buy | 7,253 | N/A |
| 2024-03-28 | Boxus Joëlle | Executive member | Buy | 5,181 | N/A |
| 2024-03-27 | Tiberghien Hervé | Executive member | Buy | 2,798 | N/A |
| 2024-03-13 | Rollinger Mark | Executive member | Buy | 618 | 50,155.58 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |